Open Access
Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
Cheng Xu Ma
1, 2
,
Xiao-Ni Ma
1, 2
,
Cong Hui Guan
1, 2
,
Ying Dong Li
3
,
Didac Mauricio
4
,
Song-Bo Fu
1, 2
Publication type: Journal Article
Publication date: 2022-05-14
scimago Q1
wos Q1
SJR: 3.353
CiteScore: 13.6
Impact factor: 10.6
ISSN: 14752840
PubMed ID:
35568946
Cardiology and Cardiovascular Medicine
Endocrinology, Diabetes and Metabolism
Abstract
Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2 diabetes mellitus (T2DM), particularly in low- and middle-income countries. To effectively prevent the development of CVDs in T2DM, considerable effort has been made to explore novel preventive approaches, individualized glycemic control and cardiovascular risk management (strict blood pressure and lipid control), together with recently developed glucose-lowering agents and lipid-lowering drugs. This review mainly addresses the important issues affecting the choice of antidiabetic agents and lipid, blood pressure and antiplatelet treatments considering the cardiovascular status of the patient. Finally, we also discuss the changes in therapy principles underlying CVDs in T2DM.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
16
18
20
|
|
|
Cardiovascular Diabetology
19 publications, 6.57%
|
|
|
Frontiers in Endocrinology
12 publications, 4.15%
|
|
|
Cureus
10 publications, 3.46%
|
|
|
Diabetology and Metabolic Syndrome
8 publications, 2.77%
|
|
|
Scientific Reports
8 publications, 2.77%
|
|
|
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
7 publications, 2.42%
|
|
|
Frontiers in Cardiovascular Medicine
6 publications, 2.08%
|
|
|
Biomedicines
6 publications, 2.08%
|
|
|
Diabetes, Obesity and Metabolism
6 publications, 2.08%
|
|
|
International Journal of Molecular Sciences
5 publications, 1.73%
|
|
|
Nutrients
5 publications, 1.73%
|
|
|
Medicina
5 publications, 1.73%
|
|
|
World Journal of Diabetes
4 publications, 1.38%
|
|
|
Frontiers in Nutrition
4 publications, 1.38%
|
|
|
Journal of Clinical Medicine
4 publications, 1.38%
|
|
|
BMC Cardiovascular Disorders
3 publications, 1.04%
|
|
|
Heliyon
3 publications, 1.04%
|
|
|
Current Diabetes Reviews
3 publications, 1.04%
|
|
|
BMC Endocrine Disorders
3 publications, 1.04%
|
|
|
International Journal of Cardiology
3 publications, 1.04%
|
|
|
Frontiers in Pharmacology
2 publications, 0.69%
|
|
|
Molecular and Cellular Biochemistry
2 publications, 0.69%
|
|
|
Phytotherapy Research
2 publications, 0.69%
|
|
|
Journal of Diabetes and its Complications
2 publications, 0.69%
|
|
|
Pharmaceutics
2 publications, 0.69%
|
|
|
Metabolites
2 publications, 0.69%
|
|
|
Diabetes Mellitus
2 publications, 0.69%
|
|
|
Diabetology
2 publications, 0.69%
|
|
|
Life
2 publications, 0.69%
|
|
|
2
4
6
8
10
12
14
16
18
20
|
Publishers
|
10
20
30
40
50
60
70
80
|
|
|
Springer Nature
79 publications, 27.34%
|
|
|
Elsevier
47 publications, 16.26%
|
|
|
MDPI
44 publications, 15.22%
|
|
|
Frontiers Media S.A.
29 publications, 10.03%
|
|
|
Wiley
24 publications, 8.3%
|
|
|
Taylor & Francis
13 publications, 4.5%
|
|
|
Bentham Science Publishers Ltd.
7 publications, 2.42%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
7 publications, 2.42%
|
|
|
Cold Spring Harbor Laboratory
6 publications, 2.08%
|
|
|
Baishideng Publishing Group
5 publications, 1.73%
|
|
|
American Physiological Society
2 publications, 0.69%
|
|
|
Endocrinology Research Centre
2 publications, 0.69%
|
|
|
Research Square Platform LLC
2 publications, 0.69%
|
|
|
Public Library of Science (PLoS)
2 publications, 0.69%
|
|
|
BMJ
2 publications, 0.69%
|
|
|
Mary Ann Liebert
1 publication, 0.35%
|
|
|
The Endocrine Society
1 publication, 0.35%
|
|
|
Radcliffe Media Media Ltd
1 publication, 0.35%
|
|
|
SAGE
1 publication, 0.35%
|
|
|
American Diabetes Association
1 publication, 0.35%
|
|
|
PeerJ
1 publication, 0.35%
|
|
|
Georg Thieme Verlag KG
1 publication, 0.35%
|
|
|
IMR Press
1 publication, 0.35%
|
|
|
Cambridge University Press
1 publication, 0.35%
|
|
|
Oxford University Press
1 publication, 0.35%
|
|
|
Hindawi Limited
1 publication, 0.35%
|
|
|
10
20
30
40
50
60
70
80
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
289
Total citations:
289
Citations from 2024:
230
(79.58%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Ma C. X. et al. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management // Cardiovascular Diabetology. 2022. Vol. 21. No. 1. 74
GOST all authors (up to 50)
Copy
Ma C. X., Ma X., Guan C. H., Li Y. D., Mauricio D., Fu S. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management // Cardiovascular Diabetology. 2022. Vol. 21. No. 1. 74
Cite this
RIS
Copy
TY - JOUR
DO - 10.1186/s12933-022-01516-6
UR - https://doi.org/10.1186/s12933-022-01516-6
TI - Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management
T2 - Cardiovascular Diabetology
AU - Ma, Cheng Xu
AU - Ma, Xiao-Ni
AU - Guan, Cong Hui
AU - Li, Ying Dong
AU - Mauricio, Didac
AU - Fu, Song-Bo
PY - 2022
DA - 2022/05/14
PB - Springer Nature
IS - 1
VL - 21
PMID - 35568946
SN - 1475-2840
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2022_Ma,
author = {Cheng Xu Ma and Xiao-Ni Ma and Cong Hui Guan and Ying Dong Li and Didac Mauricio and Song-Bo Fu},
title = {Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management},
journal = {Cardiovascular Diabetology},
year = {2022},
volume = {21},
publisher = {Springer Nature},
month = {may},
url = {https://doi.org/10.1186/s12933-022-01516-6},
number = {1},
pages = {74},
doi = {10.1186/s12933-022-01516-6}
}